CLINICAL_TRIALS ClinicalTrials.gov record update

Essai Bayésien de Phase I/II évaluant l'efficacité et la tolérance du Danazol Chez Les Patients Ayant Une Atteinte hématologique ou Pulmonaire sévère liée à Une téloméropathie - ANDROTELO

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03710356
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:06.933706+00:00
Published At: 2018-10-18T00:00:00+00:00
Record Updated At: 2018-10-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Telomere Shortening", "Telomere Length, Mean Leukocyte"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-10-18"
protocolSection.identificationModule.nctId: "NCT03710356"
protocolSection.identificationModule.officialTitle: "Essai Bay\u00e9sien de Phase I/II \u00e9valuant l\u0027efficacit\u00e9 et la tol\u00e9rance du Danazol Chez Les Patients Ayant Une Atteinte h\u00e9matologique ou Pulmonaire s\u00e9v\u00e8re li\u00e9e \u00e0 Une t\u00e9lom\u00e9ropathie - ANDROTELO"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.